Renaissance Global Science & Tech (USD) (ATL1227)
94.34
-0.13 (-0.13%)
USD |
May 19 2022
Returns Chart
Key Stats
Customize
| Expense Ratio | Total Assets Under Management | Dividend Yield | Turnover Ratio |
|---|---|---|---|
| 2.60% | 143.89M | 0.00% | -- |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized All Time Total Returns (Daily) | Max Drawdown (All) |
| 28.15M | -18.89% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| To obtain long-term capital appreciation by investing in a diversified portfolio of global companies involved mainly in telecommunications, biotechnology, computer hardware and software, and medical services and other scientific and technology based companies. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | ATL1027 |
| Equity Style | Large Cap/Growth |
| Fixed Income Style | -- |
| Broad Asset Class | -- |
| Broad Category | Equity |
| Category Name | Global Equity |
| Category Index | -- |
| Prospectus Objective | -- |
| Fund Owner Firm Name | CIBC Asset Management Inc |
| Prospectus Benchmark Index | |
| MSCI World Information Tech CAD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPTSX60TR | 100.0% |
| Manager Tenure | |
| Jonathan Mzengeza | 3.17 yrs |
| Michal Marszal | 2.89 yrs |
| Craig Jerusalim | 1.09 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
34
28.15M
-534.39M
Category Low
4.218B
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of May 31, 2020
Performance Versus Category
As of May 19, 2022. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
As of May 19, 2022.
Asset Allocation
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Microsoft Corp | 8.78% | 253.14 | -0.37% |
| Apple Inc | 6.74% | 137.35 | -2.46% |
|
Takeda Pharmaceutical Co Ltd
|
4.37% | -- | -- |
| Alibaba Group Holding Ltd ADR | 3.98% | 87.69 | 0.44% |
| Tencent Holdings Ltd ADR | 3.97% | 44.87 | 3.13% |
| Mastercard Inc A | 3.92% | 332.22 | -1.10% |
| Amazon.com Inc | 3.91% | 2146.38 | 0.19% |
| CVS Health Corp | 3.87% | 93.14 | -0.94% |
| Taiwan Semiconductor Manufacturing Co Ltd ADR | 3.61% | 90.21 | -0.35% |
| Alphabet Inc A | 3.57% | 2207.68 | -1.35% |
Basic Info
| Investment Strategy | |
| To obtain long-term capital appreciation by investing in a diversified portfolio of global companies involved mainly in telecommunications, biotechnology, computer hardware and software, and medical services and other scientific and technology based companies. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | ATL1027 |
| Equity Style | Large Cap/Growth |
| Fixed Income Style | -- |
| Broad Asset Class | -- |
| Broad Category | Equity |
| Category Name | Global Equity |
| Category Index | -- |
| Prospectus Objective | -- |
| Fund Owner Firm Name | CIBC Asset Management Inc |
| Prospectus Benchmark Index | |
| MSCI World Information Tech CAD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPTSX60TR | 100.0% |
| Manager Tenure | |
| Jonathan Mzengeza | 3.17 yrs |
| Michal Marszal | 2.89 yrs |
| Craig Jerusalim | 1.09 yrs |
Fundamentals
| General | |
| Distribution Yield | Upgrade |
| Dividend Yield TTM (5-19-22) | 0.00% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Number of Holdings | Upgrade |
| Stock | |
| Weighted Average PE Ratio | 26.27 |
| Weighted Average Price to Sales Ratio | Upgrade |
| Weighted Average Price to Book Ratio | Upgrade |
| Weighted Median ROE | Upgrade |
| Weighted Median ROA | Upgrade |
| Forecasted Dividend Yield | Upgrade |
| Forecasted PE Ratio | Upgrade |
| Forecasted Price to Sales Ratio | Upgrade |
| Forecasted Price to Book Ratio | Upgrade |
As of February 29, 2020
Growth Estimates
Fund Details
| Key Dates | |
| Inception Date | 10/28/1996 |
| Last Annual Report Date | 8/31/2019 |
| Last Prospectus Date | -- |
| Share Classes | |
| ATL1027 | Commission-based Advice |
| ATL1637 | -- |
| ATL1645 | Fee-based Advice |
| ATL1745 | Institutional |
| ATL6737 | -- |
| Attributes | |
| Enhanced Index Fund | No |
| Index Fund | No |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan |
|
| Socially Responsible Fund | No |